Co-Authors
This is a "connection" page, showing publications co-authored by Hendrik Schulze-Koops and Bimba Hoyer.
Connection Strength
0.970
-
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2-methodology, key messages and justifying information. Rheumatology (Oxford). 2021 05 14; 60(5):2128-2133.
Score: 0.236
-
[Recommendations of the German Society for Rheumatology for management of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic - Update July 2020]. Z Rheumatol. 2020 Sep; 79(7):679-685.
Score: 0.225
-
[Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic]. Z Rheumatol. 2020 May; 79(4):385-388.
Score: 0.220
-
[German registry www.Covid19-Rheuma.de : Status report after 1 year of the pandemic]. Z Rheumatol. 2021 Sep; 80(7):641-646.
Score: 0.060
-
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis? Clin Exp Rheumatol. 2021 May-Jun; 39(3):639-647.
Score: 0.059
-
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases. RMD Open. 2021 01; 7(1).
Score: 0.058
-
National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD. RMD Open. 2020 09; 6(2).
Score: 0.056
-
[SARS-CoV-2 & rheumatic disease : Consequences of the SARS-CoV-2 pandemic for patients with inflammatory rheumatic diseases. A comparison of the recommendations for action of rheumatological societies and risk assessment of different antirheumatic treatments]. Z Rheumatol. 2020 Sep; 79(7):686-691.
Score: 0.056